SE7910300L - Farmaceptisk komposition for behandling av neoplastiska sjukdomar och forfarande for dess framstellning - Google Patents
Farmaceptisk komposition for behandling av neoplastiska sjukdomar och forfarande for dess framstellningInfo
- Publication number
- SE7910300L SE7910300L SE7910300A SE7910300A SE7910300L SE 7910300 L SE7910300 L SE 7910300L SE 7910300 A SE7910300 A SE 7910300A SE 7910300 A SE7910300 A SE 7910300A SE 7910300 L SE7910300 L SE 7910300L
- Authority
- SE
- Sweden
- Prior art keywords
- procedures
- preparation
- treatment
- pharmaceutical composition
- neoplastic diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/971,729 US4384001A (en) | 1978-12-21 | 1978-12-21 | Treatment of tumors with thiazolidine-4-carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7910300L true SE7910300L (sv) | 1980-06-22 |
Family
ID=25518727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7910300A SE7910300L (sv) | 1978-12-21 | 1979-12-14 | Farmaceptisk komposition for behandling av neoplastiska sjukdomar och forfarande for dess framstellning |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4384001A (sv) |
| JP (1) | JPS55115822A (sv) |
| AU (1) | AU5390579A (sv) |
| BE (1) | BE880744A (sv) |
| CA (1) | CA1149284A (sv) |
| DE (1) | DE2951050A1 (sv) |
| DK (1) | DK542979A (sv) |
| ES (1) | ES487052A0 (sv) |
| FR (1) | FR2444459A1 (sv) |
| GB (1) | GB2039736B (sv) |
| IL (1) | IL58948A0 (sv) |
| IT (1) | IT1193348B (sv) |
| LU (1) | LU82013A1 (sv) |
| NL (1) | NL7909199A (sv) |
| SE (1) | SE7910300L (sv) |
| ZA (1) | ZA796918B (sv) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE53332B1 (en) * | 1980-03-14 | 1988-10-26 | Efamol Ltd | Pharmaceutical compositions |
| JPS57128625A (en) * | 1981-01-30 | 1982-08-10 | Rikagaku Kenkyusho | Carcinostatic |
| US4335210A (en) * | 1981-02-11 | 1982-06-15 | Cornell Research Foundation | Method of producing L-cysteine |
| FR2547728B1 (fr) * | 1983-06-24 | 1986-05-02 | Riker Laboratories Inc | Medicament a base d'acide d thiazolidine carboxylique |
| FR2547729B1 (fr) * | 1983-06-24 | 1986-05-02 | Riker Laboratories Inc | Medicament a base d'acide dl thiazolidine carboxylique |
| JPS62501769A (ja) * | 1984-12-18 | 1987-07-16 | デイビツト ラビン | 細胞毒性アルデヒドとベニシラミンとの反応性成物を含有する抗腫瘍組成物及びその使用方法 |
| JPH066578B2 (ja) * | 1985-12-27 | 1994-01-26 | 三共株式会社 | チアゾリジン誘導体 |
| JPH01170063U (sv) * | 1988-05-11 | 1989-11-30 | ||
| JPH0467539U (sv) * | 1990-10-18 | 1992-06-16 | ||
| DE69214467T3 (de) * | 1991-01-10 | 2000-09-28 | Transcend Therapeutics Inc | Verwendung von L-2-oxo Thiazolidin-4-carboxylat zur Behandlung von Atemnotsyndrom |
| ES2277787B1 (es) * | 2006-01-02 | 2008-06-16 | Universidad De Cadiz | Empleo de tioprolina en tratamientos de reduccion de peso corporal. |
-
1978
- 1978-12-21 US US05/971,729 patent/US4384001A/en not_active Expired - Lifetime
-
1979
- 1979-12-12 GB GB7942753A patent/GB2039736B/en not_active Expired
- 1979-12-13 IL IL58948A patent/IL58948A0/xx unknown
- 1979-12-14 SE SE7910300A patent/SE7910300L/sv unknown
- 1979-12-17 AU AU53905/79A patent/AU5390579A/en not_active Abandoned
- 1979-12-18 IT IT28170/79A patent/IT1193348B/it active
- 1979-12-19 DE DE19792951050 patent/DE2951050A1/de not_active Withdrawn
- 1979-12-19 LU LU82013A patent/LU82013A1/fr unknown
- 1979-12-19 BE BE0/198657A patent/BE880744A/fr not_active IP Right Cessation
- 1979-12-19 FR FR7931158A patent/FR2444459A1/fr active Granted
- 1979-12-19 CA CA000342263A patent/CA1149284A/en not_active Expired
- 1979-12-19 ES ES487052A patent/ES487052A0/es active Granted
- 1979-12-19 DK DK542979A patent/DK542979A/da unknown
- 1979-12-20 JP JP16495079A patent/JPS55115822A/ja active Granted
- 1979-12-20 ZA ZA00796918A patent/ZA796918B/xx unknown
- 1979-12-20 NL NL7909199A patent/NL7909199A/nl not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2444459B1 (sv) | 1983-04-01 |
| NL7909199A (nl) | 1980-06-24 |
| BE880744A (fr) | 1980-06-19 |
| FR2444459A1 (fr) | 1980-07-18 |
| GB2039736B (en) | 1983-04-13 |
| AU5390579A (en) | 1980-06-26 |
| DE2951050A1 (de) | 1980-07-10 |
| IL58948A0 (en) | 1980-03-31 |
| IT1193348B (it) | 1988-06-15 |
| CA1149284A (en) | 1983-07-05 |
| US4384001A (en) | 1983-05-17 |
| ZA796918B (en) | 1980-11-26 |
| ES8102108A1 (es) | 1980-12-16 |
| IT7928170A0 (it) | 1979-12-18 |
| ES487052A0 (es) | 1980-12-16 |
| JPS55115822A (en) | 1980-09-06 |
| JPS6328045B2 (sv) | 1988-06-07 |
| DK542979A (da) | 1980-06-22 |
| GB2039736A (en) | 1980-08-20 |
| LU82013A1 (fr) | 1981-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO152635C (no) | Fremgangsmaate for fremstilling av cyklosporinholdige farmasoeytiske preparater i flytende form | |
| FI792863A (fi) | Foerfarande foer igaongsaettning av aongpanna med tvaongscirkulation | |
| JPS5643217A (en) | Water drug for external application for trauma treatment and manufacture thereof | |
| NO150360C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider | |
| DE2963572D1 (en) | Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions | |
| NO151201C (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater | |
| SE7900792L (sv) | 2h-bensofuran-3-on-derivat och forfarande for framstellning av dem | |
| SE7910300L (sv) | Farmaceptisk komposition for behandling av neoplastiska sjukdomar och forfarande for dess framstellning | |
| NO151319C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser | |
| SE7804711L (sv) | Forfarande for framstellning av fenolformaldehydskum och dervid framstellda produkter | |
| NO790523L (no) | Analogifremgangsmaate for fremstilling av farmasoeytisk aktive 2-fenyliminoimidazolidiner | |
| NO152606C (no) | Analogifremgangsmaate til fremstilling av nye farmasoeytiske anvendbare 2-imidazolin-1-yl-urinstoff-og amidoforbindelser | |
| SE7808138L (sv) | Pyranokromonderivat och terapeutisk komposition innehallande detsamma for behandling av allergiska sjukdomar | |
| GB2022998B (en) | Phermaceutical composition for the treatment of neoplasticand other diseases | |
| SE7612141L (sv) | Forfarande och mellanprodukter for framstellning av kinoliner | |
| SE7802024L (sv) | Forfarande for framstellning av pyrrolokinoxalinoner och pyrrolobensodiazepinoner | |
| FI792303A (fi) | Farmaceutisk komposition foer rektal administration av kefalosporin | |
| EG14024A (en) | Pharmaceutical compositions and their use in the profyloxis and or treatment of certain diseases | |
| SE7807795L (sv) | Sjelvlasande mutterforband och forfarande for tillverkning av dessa | |
| NO147103C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme forbindelser | |
| SE417086B (sv) | Forfarande for framstellning av 2-etylindan och 2-isopropylindan | |
| JPS55122712A (en) | Novel medicine state of oral drug and its manufacture | |
| JPS5562009A (en) | Manufacture of ammoxysilinsodium medicine | |
| AR219372A1 (es) | Procedimiento de preparacion de nuevas preparaciones farmaceuticas destinadas al tratamiento de las enfermedades virales | |
| SE8006150L (sv) | Forfarande och anordning for framstellning av cyanvete |